SPHK2 and neoplasm: Earlier, we reported that in approximately two-thirds of OSCC patients studied, mRNA expression of SphK2 and lipid phosphate phosphatase 3 (LPP3) was significantly downregulated in tumor tissues, compared with the same patient’s adjacent normal tissue [14].